These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7468766)

  • 1. Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy.
    Orr FW; Varani J; Delikatny J; Jain N; Ward PA
    Am J Pathol; 1981 Feb; 102(2):160-7. PubMed ID: 7468766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide.
    Wass JA; Varani J; Piontek GE; Ward PA; Orr FW
    Cell Differ; 1981 Dec; 10(6):329-32. PubMed ID: 7317948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice.
    Weiss L; Glaves D
    Int J Cancer; 1976 Dec; 18(6):774-7. PubMed ID: 1036490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
    Algarra I; Collado A; Garrido F
    J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotactic response of tumor cells. A model for cancer metastasis.
    Lam WC; Delikatny EJ; Orr FW; Wass J; Varani J; Ward PA
    Am J Pathol; 1981 Jul; 104(1):69-76. PubMed ID: 7258297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence.
    Edelman AS; Xue B; Galton JE; Sanchez P; Thorbecke GJ
    J Immunol; 1985 Sep; 135(3):2213-9. PubMed ID: 3926899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
    Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
    J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic stability of murine tumor cells in vitro and in vivo.
    Varani J; Lovett EJ
    J Natl Cancer Inst; 1982 Jun; 68(6):957-62. PubMed ID: 6953274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced experimental metastasis of ultraviolet light-induced fibrosarcomas in ultraviolet light-irradiated syngeneic mice.
    Kripke ML; Fidler IJ
    Cancer Res; 1980 Mar; 40(3):625-9. PubMed ID: 6451287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
    Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
    Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of in vivo immunity to tumor-specific transplantation antigens of chemically induced murine fibrosarcomas.
    Parmiani G; Ballinari D
    Int J Cancer; 1979 May; 23(5):697-705. PubMed ID: 88423
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro demonstration of cryosurgical augmentation of tumor immunity.
    Faraci RP; Bagley DH; Marrone J; Beazley RM
    Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.
    Orr FW; Mokashi S; Delikatny J
    Am J Pathol; 1982 Jul; 108(1):112-8. PubMed ID: 7091299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.